JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M707422200 on February 24, 2008

J. Biol. Chem., Vol. 283, Issue 18, 11954-11963, May 2, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/18/11954    most recent
M707422200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Means, C. K.
Right arrow Articles by Brown, J. H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Means, C. K.
Right arrow Articles by Brown, J. H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

S1P1 Receptor Localization Confers Selectivity for Gi-mediated cAMP and Contractile Responses*Formula

Christopher Kable Means{ddagger}§, Shigeki Miyamoto§, Jerold Chun, and Joan Heller Brown§1

From the {ddagger}Biomedical Sciences Graduate Program and §Department of Pharmacology, University of California, San Diego, California 92093-0636 and the Department of Molecular Biology, The Scripps Research Institute, La Jolla, California 92037

Adult mouse ventricular myocytes express S1P1, S1P2, and S1P3 receptors. S1P activates Akt and ERK in adult mouse ventricular myocytes through a pertussis toxin-sensitive (Gi/o-mediated) pathway. Akt and ERK activation by S1P are reduced ~30% in S1P3 and 60% in S1P2 receptor knock-out myocytes. With combined S1P2,3 receptor deletion, activation of Akt is abolished and ERK activation is reduced by nearly 90%. Thus the S1P1 receptor, while present in S1P2,3 receptor knock-out myocytes, is unable to mediate Akt or ERK activation. In contrast, S1P induces pertussis toxin-sensitive inhibition of isoproterenol-stimulated cAMP accumulation in both WT and S1P2,3 receptor knock-out myocytes demonstrating that the S1P1 receptor can functionally couple to Gi. An S1P1 receptor selective agonist, SEW2871, also decreased cAMP accumulation but failed to activate ERK or Akt. To determine whether localization of the S1P1 receptor mediates this signaling specificity, methyl-β-cyclodextrin (MβCD) treatment was used to disrupt caveolae. The S1P1 receptor was concentrated in caveolar fractions, and associated with caveolin-3 and this localization was disrupted by MβCD. S1P-mediated activation of ERK or Akt was not diminished but inhibition of cAMP accumulation by S1P and SEW2871 was abolished by MβCD treatment. S1P inhibits the positive inotropic response to isoproterenol and this response is also mediated through the S1P1 receptor and lost following caveolar disruption. Thus localization of S1P1 receptors to caveolae is required for the ability of this receptor to inhibit adenylyl cyclase and contractility but compromises receptor coupling to Akt and ERK.


Received for publication, September 5, 2007 , and in revised form, February 5, 2008.

Note Added in Proof—A paper that appeared while this manuscript was under review reports experiments using an S1P1 receptor agonist antibody to demonstrate that the S1P1 receptor can activate Akt and thus protect adult mouse myocytes from hypoxia (53).

* This work was supported by National Institutes of Health Grants HL28143 and HL46345 (to J. H. B.), and NS048478 and DA019674 (to J. C.) and an American Heart Association predoctoral fellowship (to C. K. M.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1–S2.

1 To whom correspondence should be addressed: 9500 Gilman Dr., La Jolla, CA 92093-0636. E-mail: jhbrown{at}ucsd.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.